We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Gemtuzumab ozogamicin

Australian Public Assessment Report

AusPAR

AusPAR: Gemtuzumab ozogamicin [PDF, 732.24 KB]

AusPAR: Gemtuzumab ozogamicin [Word, 1.42 MB]

Attachment: Product Information for Gemtuzumab ozogamicin [PDF, 316.29 KB]

Attachment: Product Information for Gemtuzumab ozogamicin [Word, 198.84 KB]

Device/Product Name

Mylotarg

Active ingredients

Gemtuzumab ozogamicin

AusPAR Date

8 October 2020

Published

20 October 2020

Submission Number

PM-2019-01426-1-6

Submission Type

New biological entity

Decision

Approved